Valuation: Acutaas Chemicals Limited

Capitalization 139B 1.53B 1.32B 1.23B 1.15B 2.13B 2.3B 14.16B 5.58B 66.37B 5.75B 5.63B 242B P/E ratio 2026 *
51.3x
P/E ratio 2027 * 40.3x
Enterprise value 136B 1.5B 1.29B 1.2B 1.12B 2.09B 2.24B 13.84B 5.46B 64.9B 5.62B 5.51B 237B EV / Sales 2026 *
10.7x
EV / Sales 2027 * 8.35x
Free-Float
52.71%
Yield 2026 *
0.13%
Yield 2027 * 0.15%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.61%
1 week+0.85%
Current month-0.31%
1 month+2.27%
3 months+3.20%
6 months+40.63%
Current year-0.31%
More quotes
1 week 1,641.9
Extreme 1641.9
1,749.2
1 month 1,615.8
Extreme 1615.8
1,807.8
Current year 1,641.9
Extreme 1641.9
1,807.8
1 year 918.78
Extreme 918.775
1,902
3 years 423.68
Extreme 423.675
1,902
5 years 383.05
Extreme 383.05
1,902
10 years 383.05
Extreme 383.05
1,902
More quotes
Manager TitleAgeSince
Chief Executive Officer 51 11/07/2007
Director of Finance/CFO 48 31/05/2022
Chief Tech/Sci/R&D Officer 63 -
Director TitleAgeSince
Chairman 51 11/07/2007
Director/Board Member 51 11/07/2007
Director/Board Member 64 22/04/2018
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.61%+0.85%+69.59%+282.60% 1.53B
+0.62%+11.26%+11.88%+71.23% 67.44B
-3.67%-0.78%+0.34%-15.61% 45.71B
-1.25%-0.52%+4.97%+21.16% 16.56B
+1.58%+4.88%+46.75%+61.58% 13.02B
-0.13%+0.15%+16.16%+38.27% 9.89B
+1.57%+6.51%+31.92%+46.94% 8.73B
-2.88%+1.55%-2.44% - 8.53B
-3.97%+0.74%-10.49%-26.22% 8.43B
-2.63%0.00%-2.91%-8.26% 5.49B
Average -1.14%+2.46%+16.58%+52.41% 18.53B
Weighted average by Cap. -1.01%+4.63%+10.40%+35.05%
See all sector performances

Financials

2026 *2027 *
Net sales 12.75B 141M 121M 113M 105M 196M 210M 1.3B 512M 6.08B 527M 516M 22.21B 16.2B 179M 154M 143M 133M 248M 267M 1.65B 650M 7.73B 669M 656M 28.21B
Net income 2.72B 29.96M 25.83M 24.04M 22.38M 41.67M 44.84M 277M 109M 1.3B 112M 110M 4.73B 3.39B 37.34M 32.19M 29.97M 27.9M 51.95M 55.89M 345M 136M 1.62B 140M 137M 5.9B
Net Debt -3.08B -33.94M -29.26M -27.24M -25.36M -47.22M -50.8M -313M -124M -1.47B -127M -125M -5.36B -3.9B -42.98M -37.05M -34.49M -32.11M -59.79M -64.32M -397M -156M -1.86B -161M -158M -6.79B
More financial data * Estimated data
Logo Acutaas Chemicals Limited
Ami Organics Limited is an India-based manufacturer of pharma intermediates and specialty chemicals. The Company is focused on the development and manufacturing of advanced pharmaceutical intermediates (Pharma Intermediates), New Chemical Entities (NCE) and other specialty chemicals for pharmaceuticals, agrochemicals, dyes, polymers, personal care, animal food, and other Industries. It manufactures pharma intermediates for certain active pharmaceutical ingredient (APIs), including dolutegravir, trazodone, entacapone, nintedanib, and rivaroxaban. The pharma intermediates cater to several therapeutic areas, including anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson, anti-depressant, and anti-coagulant. The Company has developed and commercialized over 520 plus products including specialty chemicals, Pharma Intermediates for APIs across 23 key therapeutic areas since inception and NCE across select high-growth high margin chronic therapeutic areas.
Employees
879
More about the company
Date Price Change Volume
16/01/26 1,699.60 -0.61% 206,418
14/01/26 1,710.00 +1.59% 263,257
13/01/26 1,683.30 +0.41% 135,721
12/01/26 1,676.50 -0.52% 309,476
09/01/26 1,685.20 -2.98% 418,733

End-of-day quote NSE India S.E., January 15, 2026

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
1,699.60INR
Average target price
1,833.00INR
Spread / Average Target
+7.85%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. ACUTAAS Stock